The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis

Abstract Background Epilepsy surgery is an established treatment for drug-resistant focal epilepsy (DRFE) that results in seizure freedom in about 60% of patients. Correctly identifying an epileptogenic lesion in magnetic resonance imaging (MRI) is challenging but highly relevant since it improves t...

Full description

Bibliographic Details
Main Authors: Leonhard Mann, Felix Rosenow, Adam Strzelczyk, Elke Hattingen, Laurent M. Willems, Patrick N. Harter, Katharina Weber, Catrin Mann
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Neurological Research and Practice
Subjects:
Online Access:https://doi.org/10.1186/s42466-023-00288-y
_version_ 1827581321203941376
author Leonhard Mann
Felix Rosenow
Adam Strzelczyk
Elke Hattingen
Laurent M. Willems
Patrick N. Harter
Katharina Weber
Catrin Mann
author_facet Leonhard Mann
Felix Rosenow
Adam Strzelczyk
Elke Hattingen
Laurent M. Willems
Patrick N. Harter
Katharina Weber
Catrin Mann
author_sort Leonhard Mann
collection DOAJ
description Abstract Background Epilepsy surgery is an established treatment for drug-resistant focal epilepsy (DRFE) that results in seizure freedom in about 60% of patients. Correctly identifying an epileptogenic lesion in magnetic resonance imaging (MRI) is challenging but highly relevant since it improves the likelihood of being referred for presurgical diagnosis. The epileptogenic lesion’s etiology directly relates to the surgical intervention’s indication and outcome. Therefore, it is vital to correctly identify epileptogenic lesions and their etiology presurgically. Methods We compared the final histopathological diagnoses of all patients with DRFE undergoing epilepsy surgery at our center between 2015 and 2021 with their MRI diagnoses before and after presurgical diagnosis at our epilepsy center, including MRI evaluations by expert epilepsy neuroradiologists. Additionally, we analyzed the outcome of different subgroups. Results This study included 132 patients. The discordance between histopathology and MRI diagnoses significantly decreased from 61.3% for non-expert MRI evaluations (NEMRIs) to 22.1% for epilepsy center MRI evaluations (ECMRIs; p < 0.0001). The MRI-sensitivity improved significantly from 68.6% for NEMRIs to 97.7% for ECMRIs (p < 0.0001). Identifying focal cortical dysplasia (FCD) and amygdala dysplasia was the most challenging for both subgroups. 65.5% of patients with negative NEMRI were seizure-free 12 months postoperatively, no patient with negative ECMRI achieved seizure-freedom. The mean duration of epilepsy until surgical intervention was 13.6 years in patients with an initial negative NEMRI and 9.5 years in patients with a recognized lesion in NEMRI. Conclusions This study provides evidence that for patients with DRFE—especially those with initial negative findings in a non-expert MRI—an early consultation at an epilepsy center, including an ECMRI, is important for identifying candidates for epilepsy surgery. NEMRI-negative findings preoperatively do not preclude seizure freedom postoperatively. Therefore, patients with DRFE that remain MRI-negative after initial NEMRI should be referred to an epilepsy center for presurgical evaluation. Nonreferral based on NEMRI negativity may harm such patients and delay surgical intervention. However, ECMRI-negative patients have a reduced chance of becoming seizure-free after epilepsy surgery. Further improvements in MRI technique and evaluation are needed and should be directed towards improving sensitivity for FCDs and amygdala dysplasias.
first_indexed 2024-03-08T22:34:43Z
format Article
id doaj.art-da394ff587d14de188e7d6039caf7f0a
institution Directory Open Access Journal
issn 2524-3489
language English
last_indexed 2024-03-08T22:34:43Z
publishDate 2023-12-01
publisher BMC
record_format Article
series Neurological Research and Practice
spelling doaj.art-da394ff587d14de188e7d6039caf7f0a2023-12-17T12:34:14ZengBMCNeurological Research and Practice2524-34892023-12-015111010.1186/s42466-023-00288-yThe impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosisLeonhard Mann0Felix Rosenow1Adam Strzelczyk2Elke Hattingen3Laurent M. Willems4Patrick N. Harter5Katharina Weber6Catrin Mann7Epilepsy Center Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, Goethe UniversityEpilepsy Center Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, Goethe UniversityEpilepsy Center Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, Goethe UniversityDepartment of Neuroradiology, University Hospital Frankfurt, Goethe University FrankfurtEpilepsy Center Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, Goethe UniversityNeurological Institute (Edinger Institute), University Hospital Frankfurt, Goethe UniversityNeurological Institute (Edinger Institute), University Hospital Frankfurt, Goethe UniversityEpilepsy Center Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, Goethe UniversityAbstract Background Epilepsy surgery is an established treatment for drug-resistant focal epilepsy (DRFE) that results in seizure freedom in about 60% of patients. Correctly identifying an epileptogenic lesion in magnetic resonance imaging (MRI) is challenging but highly relevant since it improves the likelihood of being referred for presurgical diagnosis. The epileptogenic lesion’s etiology directly relates to the surgical intervention’s indication and outcome. Therefore, it is vital to correctly identify epileptogenic lesions and their etiology presurgically. Methods We compared the final histopathological diagnoses of all patients with DRFE undergoing epilepsy surgery at our center between 2015 and 2021 with their MRI diagnoses before and after presurgical diagnosis at our epilepsy center, including MRI evaluations by expert epilepsy neuroradiologists. Additionally, we analyzed the outcome of different subgroups. Results This study included 132 patients. The discordance between histopathology and MRI diagnoses significantly decreased from 61.3% for non-expert MRI evaluations (NEMRIs) to 22.1% for epilepsy center MRI evaluations (ECMRIs; p < 0.0001). The MRI-sensitivity improved significantly from 68.6% for NEMRIs to 97.7% for ECMRIs (p < 0.0001). Identifying focal cortical dysplasia (FCD) and amygdala dysplasia was the most challenging for both subgroups. 65.5% of patients with negative NEMRI were seizure-free 12 months postoperatively, no patient with negative ECMRI achieved seizure-freedom. The mean duration of epilepsy until surgical intervention was 13.6 years in patients with an initial negative NEMRI and 9.5 years in patients with a recognized lesion in NEMRI. Conclusions This study provides evidence that for patients with DRFE—especially those with initial negative findings in a non-expert MRI—an early consultation at an epilepsy center, including an ECMRI, is important for identifying candidates for epilepsy surgery. NEMRI-negative findings preoperatively do not preclude seizure freedom postoperatively. Therefore, patients with DRFE that remain MRI-negative after initial NEMRI should be referred to an epilepsy center for presurgical evaluation. Nonreferral based on NEMRI negativity may harm such patients and delay surgical intervention. However, ECMRI-negative patients have a reduced chance of becoming seizure-free after epilepsy surgery. Further improvements in MRI technique and evaluation are needed and should be directed towards improving sensitivity for FCDs and amygdala dysplasias.https://doi.org/10.1186/s42466-023-00288-yEpilepsyMRIEpilepsy centerNon-expert MRIReferral
spellingShingle Leonhard Mann
Felix Rosenow
Adam Strzelczyk
Elke Hattingen
Laurent M. Willems
Patrick N. Harter
Katharina Weber
Catrin Mann
The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis
Neurological Research and Practice
Epilepsy
MRI
Epilepsy center
Non-expert MRI
Referral
title The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis
title_full The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis
title_fullStr The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis
title_full_unstemmed The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis
title_short The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis
title_sort impact of referring patients with drug resistant focal epilepsy to an epilepsy center for presurgical diagnosis
topic Epilepsy
MRI
Epilepsy center
Non-expert MRI
Referral
url https://doi.org/10.1186/s42466-023-00288-y
work_keys_str_mv AT leonhardmann theimpactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT felixrosenow theimpactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT adamstrzelczyk theimpactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT elkehattingen theimpactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT laurentmwillems theimpactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT patricknharter theimpactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT katharinaweber theimpactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT catrinmann theimpactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT leonhardmann impactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT felixrosenow impactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT adamstrzelczyk impactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT elkehattingen impactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT laurentmwillems impactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT patricknharter impactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT katharinaweber impactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis
AT catrinmann impactofreferringpatientswithdrugresistantfocalepilepsytoanepilepsycenterforpresurgicaldiagnosis